BiotechTube
Home/Zelluna Immunotherapy/Anders Holm
AH

Anders Holm

Chief Operating Officer & Head of Business Development

Zelluna Immunotherapy

Therapeutic Areas

OncologySolid Tumors

Zelluna Immunotherapy Pipeline

DrugIndicationPhase
Proprietary TCR-NK PlatformUndisclosed Solid TumorsPreclinical

Leadership Team at Zelluna Immunotherapy

NH
Namir Hassan
Chief Executive Officer
GC
Geir Christian Melen
Chief Financial Officer
LW
Luise Weigand
Chief Scientific Officer
EG
Emilie Gauthy
Chief Technology Officer/Head of CMC
WH
Wolf Hervé Fridman
Scientific Advisory Board Member
OH
Omid Hamid
Scientific Advisory Board Member
DJ
Dirk Jäger
Scientific Advisory Board Member
View full Zelluna Immunotherapy profile